181 related articles for article (PubMed ID: 33320410)
1. Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO-Head and Neck working group.
Franzese C; Ingargiola R; Tomatis S; Iacovelli NA; Beltramo G; Franco P; Bonomo P; Zanetti IB; Argenone A; Cante D; Romanello DA; Musio D; De Felice F; Furlan C; Scorsetti M; Orlandi E
Oral Dis; 2022 Mar; 28(2):345-351. PubMed ID: 33320410
[TBL] [Abstract][Full Text] [Related]
2. Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer.
Franzese C; Badalamenti M; Teriaca A; De Virgilio A; Mercante G; Cavina R; Ferrari D; Santoro A; Spriano G; Scorsetti M
J Cancer Res Clin Oncol; 2021 May; 147(5):1307-1313. PubMed ID: 33471186
[TBL] [Abstract][Full Text] [Related]
3. The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group.
Franzese C; Marvaso G; Francolini G; Borghetti P; Trodella LE; Sepulcri M; Matrone F; Nicosia L; Timon G; Ognibene L; Vinciguerra A; Alongi F; Bortolus R; Corti L; Ramella S; Magrini SM; Livi L; Jereczek-Fossa BA; Scorsetti M; Arcangeli S
Clin Exp Metastasis; 2021 Dec; 38(6):527-537. PubMed ID: 34748125
[TBL] [Abstract][Full Text] [Related]
4. A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.
Macchia G; Lazzari R; Colombo N; Laliscia C; Capelli G; D'Agostino GR; Deodato F; Maranzano E; Ippolito E; Ronchi S; Paiar F; Scorsetti M; Cilla S; Ingargiola R; Huscher A; Cerrotta AM; Fodor A; Vicenzi L; Russo D; Borghesi S; Perrucci E; Pignata S; Aristei C; Morganti AG; Scambia G; Valentini V; Jereczek-Fossa BA; Ferrandina G
Oncologist; 2020 Feb; 25(2):e311-e320. PubMed ID: 32043791
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy for adenoid cystic carcinoma metastatic to the lung: a case report.
Kobayashi D; Abe T; Saitoh JI; Oike T; Sato H; Musha A; Mizukami T; Shimizu T; Nakano T; Ohno T
J Med Case Rep; 2021 Apr; 15(1):156. PubMed ID: 33838695
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
7. Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma.
Lee A; Givi B; Osborn VW; Schwartz D; Schreiber D
Laryngoscope; 2017 Sep; 127(9):2057-2062. PubMed ID: 28194862
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
Stefanovic M; Calvet G; Pérez-Montero H; Esteve A; Bujalance MV; Navarro-Martín A; Fernández MDA; González FF; Borras SM; Borbalas AL; Fernandez MN; Garau MM; Calduch AL; Edo FG
Clin Transl Oncol; 2023 Jan; 25(1):199-206. PubMed ID: 36068449
[TBL] [Abstract][Full Text] [Related]
10. Neutron radiotherapy for adenoid cystic carcinoma of minor salivary glands.
Douglas JG; Laramore GE; Austin-Seymour M; Koh WJ; Lindsley KL; Cho P; Griffin TW
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):87-93. PubMed ID: 8823263
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
Bonomo P; Greto D; Desideri I; Loi M; Di Cataldo V; Orlandi E; Iacovelli NA; Becherini C; Visani L; Salvestrini V; Mariotti M; Livi L
Oral Oncol; 2019 Jun; 93():1-7. PubMed ID: 31109688
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
Kim Y; Lee SJ; Lee JY; Lee SH; Sun JM; Park K; An HJ; Cho JY; Kang EJ; Lee HY; Kim J; Keam B; Kim HR; Lee KE; Choi MY; Lee KH; Ahn MJ
Cancer; 2017 Jun; 123(11):1958-1964. PubMed ID: 28102887
[TBL] [Abstract][Full Text] [Related]
13. OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO.
Mazzola R; Jereczek-Fossa BA; Antognoni P; Di Muzio N; Nicosia L; Lancia A; Fazio I; Chiesa S; Osti MF; Pergolizzi S; Franceschini D; Gentile P; Triggiani L; Alongi F
Med Oncol; 2021 Mar; 38(5):48. PubMed ID: 33761017
[TBL] [Abstract][Full Text] [Related]
14. Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.
Yeung R; Hamm J; Liu M; Schellenberg D
Radiat Oncol; 2017 Jun; 12(1):105. PubMed ID: 28637480
[TBL] [Abstract][Full Text] [Related]
15. Post-operative radiotherapy in adenoid cystic carcinoma of salivary glands versus surgery alone: what is the evidence about survival and local control? A systematic review and meta-analysis.
Scarpa A; Viola P; Ralli M; Gioacchini FM; Salzano G; Di Stadio A; Cassandro C; Chiarella G; Ricciardiello F; De Luca P; Salzano FA; Avallone E
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):563-571. PubMed ID: 37796320
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L
Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645
[TBL] [Abstract][Full Text] [Related]
17. Adenoid cystic carcinoma of the salivary glands: a review of 10 years.
Sur RK; Donde B; Levin V; Pacella J; Kotzen J; Cooper K; Hale M
Laryngoscope; 1997 Sep; 107(9):1276-80. PubMed ID: 9292617
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes and prognostic features in adenoid cystic carcinoma originated from the head and neck.
Shen C; Xu T; Huang C; Hu C; He S
Oral Oncol; 2012 May; 48(5):445-9. PubMed ID: 22209446
[TBL] [Abstract][Full Text] [Related]
19. Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.
Hsieh CE; Lin CY; Lee LY; Yang LY; Wang CC; Wang HM; Chang JT; Fan KH; Liao CT; Yen TC; Fang KH; Tsang YM
Radiat Oncol; 2016 Mar; 11():47. PubMed ID: 27000157
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis.
Franzese C; Nicosia L; Facondo G; Lo Faro L; Cuccia F; Vullo G; Osti MF; Alongi F; Scorsetti M
Clin Exp Metastasis; 2021 Dec; 38(6):511-518. PubMed ID: 34651241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
